Cor pulmonale: Difference between revisions

(Created page with "==Background== ==Clinical Features== ==Differential Diagnosis== ==Diagnosis== ==Management== ==Disposition== ==See Also== ==External Links== ==References== <re...")
 
 
(32 intermediate revisions by 7 users not shown)
Line 1: Line 1:
==Background==
==Background==
 
*Remodeling of right ventricle in response to pulmonary pathology
*Often caused by [[COPD]], [[pulmonary hypertension]], [[PE]], [[ARDS]]


==Clinical Features==
==Clinical Features==
 
===Pathophysiology===
*Pulmonary vasoconstriction ([[hypoxia]], [[acidosis|acidemia]])
*Destruction of pulmonary vasculature by emphysema, [[interstitial lung disease]]
*Increased blood viscosity ([[sickle cell disease]], [[polycythemia]])
===Chronic===
*[[RVH]]
===Acute===
*RV dilation
===Signs and Symptoms===
*[[Cough]]
*[[Dyspnea]]
*[[Tachypnea]]
*[[Hemoptysis]]
*[[Syncope]]
*Peripheral edema
*Cyanosis


==Differential Diagnosis==
==Differential Diagnosis==
*Cardiovascular
**[[ACS]]
**[[Acute Valve Dysfunction]]
**[[Aortic Dissection]]
**[[Dysrhythmia]]
**[[Endocarditis]]
**[[Hypertensive Emergency]]
**[[Pericardial Tamponade]]
*Pulmonary
**[[COPD]]
**[[PE]]
**[[pneumonia]]
*Other
**Pure [[fluid overload|volume overload]]
***[[Renal Failure]]
***Post-[[Transfusion]]
**[[Sepsis]]


==Evaluation==
===Blood tests===
*CBC ([[polycythemia]])
*[[ABG]] (oxygenation, acid-base status)
*α-1-antitrypsin
*ANA
*Coagulation studies (protein C/S, factor V Leiden etc)
===[[CXR]]===
*Enlarged pulmonary arteries
*Cardiomegaly
*Decreased retrosternal air space
===[[ECG]]===
*[[RVH]]
*Right axis deviation
*[[Right bundle branch block]]
*R:S ratio > 1 in V1
*TWI in V1-3 in acute right heart strain (as opposed to upright t-waves in posterior MI)
*S1 Q3 T3 in acute right heart strain
*Large P wave in II, III, aVF
*[[Arrhythmia]] ([[PAC]], [[SVT]], MFAT, [[A-fib]], A-[[flutter]])


==Diagnosis==
===[[Echocardiography]]===
 
*Increased RV thickness
*RV dilation
*Tricuspid insufficiency
*High estimated PA pressures
*Septal bowing into LV
===CTPA for PE===
===V/Q scan for PE===


==Management==
==Management==
 
*Treat underlying disease
*Fluids, [[vasopressors|vasoconstrictors]] to support BP in acute setting
*[[Oxygen therapy]]: decreases pulmonary vasoconstriction
*[[Diuretics]]: decrease RV filling volume
*[[Calcium channel blockers]]: vasodilate the pulmonary arteries
*Beta agonists ([[epoprostenol]], iloprost): bronchodilate
*Phlebotomy for severe hypoxia leading to polycythemia
*Lung transplant or heart-lung transplant as last resort


==Disposition==
==Disposition==
Line 18: Line 84:


==See Also==
==See Also==
 
*[[Pulmonary Embolism]]
*[[COPD]]


==External Links==
==External Links==


==References==
==References==
<references/>
<references/>


[[Category:Pulm]]
[[Category:Pulmonary]][[Category:Cardiology]]

Latest revision as of 00:51, 28 September 2023

Background

Clinical Features

Pathophysiology

Chronic

Acute

  • RV dilation

Signs and Symptoms

Differential Diagnosis

Evaluation

Blood tests

  • CBC (polycythemia)
  • ABG (oxygenation, acid-base status)
  • α-1-antitrypsin
  • ANA
  • Coagulation studies (protein C/S, factor V Leiden etc)

CXR

  • Enlarged pulmonary arteries
  • Cardiomegaly
  • Decreased retrosternal air space

ECG

Echocardiography

  • Increased RV thickness
  • RV dilation
  • Tricuspid insufficiency
  • High estimated PA pressures
  • Septal bowing into LV

CTPA for PE

V/Q scan for PE

Management

  • Treat underlying disease
  • Fluids, vasoconstrictors to support BP in acute setting
  • Oxygen therapy: decreases pulmonary vasoconstriction
  • Diuretics: decrease RV filling volume
  • Calcium channel blockers: vasodilate the pulmonary arteries
  • Beta agonists (epoprostenol, iloprost): bronchodilate
  • Phlebotomy for severe hypoxia leading to polycythemia
  • Lung transplant or heart-lung transplant as last resort

Disposition

See Also

External Links

References